ETS2 and inflammatory bowel disease: Here, we report a novel disease-specific SE in IBD and CRC that drives oncogenic ETS2 expression through long-range regulation and further elucidated how disease-associated genetic variation modulates the transcription regulation via the ETS2-SE.